Menu
Peptide Database
Results
No peptides found
Featured

Use search to browse all 100+ peptides

Thymalin

Thymulin, Thymic Factor, Serum Thymic Factor, Facteur Thymique Serique

Quick Stats
Studies 202
Trials 37
Score 3
1994 pubmed

[Effect of plasmapheresis and immunocorrective therapy on the status of the T-cell component of immunity in patients with autoimmune thyroiditis].

Kalinin. A P AP; Rafibekov. D S DS; Potemkina. E E EE; Shabadin. V N VN

Key Findings

  • Autoimmune thyroiditis patients show reduced T‑cell receptor activity and altered lymphocyte production.
  • Plasmapheresis alone provides only short‑term immune benefits.
  • Combining thymalin with plasmapheresis (and L‑thyroxine for hypothyroidism) restores T‑cell subpopulations and normalizes function for at least a year.

Practical Outcomes

  • Thymalin may be useful as an immune‑modulating add‑on for those dealing with thyroid autoimmunity, but it works best as part of a broader protocol that includes other treatments. No specific dosing is given, so anyone interested should start low, monitor thyroid function, and consult a healthcare professional before use.

Summary

The study looked at people with autoimmune thyroid disease and found that their T‑cell immune system was weakened. Using a blood‑filtering treatment (plasmapheresis) helped a little, but adding the peptide thymalin (and thyroid hormone when needed) gave a lasting improvement in immune cell balance and function over a year.

Abstract

T-cellular immunity was studied in 104 patients with autoimmune thyroiditis to assess the function of the thyroid and treatment method. A reliable reduction of the activity of T-lymphocyte receptor system, lymphopoiesis activation, and their relationship with the thyroid status were revealed. Plasmapheresis as monotherapy was used in 22 patients. It brought about a short-term positive effect, this necessitating search for other methods of immuno-rehabilitation. In 82 patients it was supplemented with immunocorrective therapy (thymalin) and in 49 with hypothyrosis with substitution therapy (L-thyroxine, thyroidin). Combined therapy helped attain a stable clinical and immunological effect. Subpopulation composition of T-lymphocytes recovered, their functional activity normalized (follow-up period 1 year).

Study Information

Provider

pubmed

Year

1994